| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |